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Abstract
Aims—To assess among injecting drug users (IDUs) in St Petersburg, Russia, the urban
environmental, social norms, and individual correlates of unsafe injecting.
Methods—Between December 2004 and January 2007 IDUs (N=446) were interviewed in St.
Petersburg, Russia.
Results—Prevalence of HCV was 96% and HIV 44%; 17% reported receptive syringe sharing after
an HIV infected IDU (RSS); 49% distributive syringe sharing (DSS); 76% sharing cookers, 73%
sharing filters and 71% syringe mediated drug sharing (SMS) when not all syringes were new. Urban
environmental characteristics correlated with sharing cookers and SMS; and social norms correlated
with RSS, DSS and sharing cookers. Individual correlates included cleaning used syringes (all five
dependent variables) and self-report of HIV infection (RSS and DSS).
Conclusion—HIV status disclosure is an unreliable but frequently used HIV prevention method
among IDUs in St. Petersburg, who reported alarmingly high levels of injecting equipment sharing.
Voluntary counseling and testing should be widely available for this population. Ethnography is
needed to assess the effectiveness of the syringe cleaning process. Prevention interventions need to
be ongoing among IDUs in St. Petersburg, and should incorporate urban environmental factors and
social norms, which may involve peer education and social network interventions.
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Introduction
Russia is among the countries with the most rapidly growing HIV rates, with injecting drug
use being the major driving force behind the epidemic [1]. As of 2005, a cumulative total of
over 300,000 HIV cases have been reported in the Russian Federation alone, over 80% of which
are attributed to drug injecting [1]. Rates of HIV among injecting drug users (IDUs) vary across
regions within Russia, ranging from 3% in Volgograd to 30% in St Petersburg and 56% in
Togliatti [1–3]. In addition, it has been estimated that about as much as 2% of the population
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in Russia injects drugs [4]. Currently methadone and buprenorphine are prohibited by law in
Russia, and only detoxification with heavy medication is available [5].
Little is known about the determinants of drug related infectious disease risk behaviors in
Russia. One important aspect is the individual characteristics of IDUs. Studies among Russian
IDUs have found an association between syringe sharing and fear of police, a history of being
arrested or incarcerated, and female gender and commercial sex work [6–8].
Another important aspect of both blood-borne pathogens, including HIV, and risk behaviors,
is the urban environment where injecting drug users reside and/or inject [9]. Many cities in
Russia, including St Petersburg, can be characterized by unique urban environments. For
example, “communal dwellings” are large formerly upper-class apartments that, in the 1920s,
the government transformed into smaller, shared (and crowded) multifamily units [10]. While
these communal dwellings are slowly disappearing, many families still live in forced physical
proximity with other families. In addition, apartment complexes in the city can be characterized
by a labyrinth of interconnected housing complexes, each almost a small city by itself. Little
is known about the relationship between urban environment and injecting risk behaviors among
IDUs in urban areas of Russia.
Social networks also play an important role in drug related infections by influencing risk
behaviors by means of social norms and social influence [11]. For example, prescriptive social
norms are norms that describe what individuals should do, while descriptive social norms are
perceptions of the behaviors of network members [12]. A unique aspect of social influence
related to drug related infections is serosorting and informed altruism. Serosorting is when
individuals practice high risk behaviors with other individuals who they believe have the same
infection status as themselves [13]. On the other hand, individuals who are infected may
practice informed altruism [14], and engage in less high-risk behaviors towards others that they
presume to be uninfected [14–16]. To date there is little empirical data on the social norms and
social influence among IDUs in Russia.
Given the crucial role of contaminated injecting equipment in the HIV/AIDS epidemic among
IDUs, it is important to identify urban environment and social influence characteristics
associated with different types of high-risk injecting in order to develop appropriate
interventions. The goal of this analysis was to assess injecting equipment sharing among IDUs
in St Petersburg, Russia. We hypothesize that injecting equipment sharing is influenced at three
levels: at the urban environmental level (influenced by factors such as neighborhood
characteristics and living conditions) [17,18]; at the level of social influence and social norms
[11]; and at the individual level (influenced by characteristics such as sociodemographics, type
and frequency of drug use, and drug trading). We anticipated different patterns of association
between the risk behaviors and these three levels. Delineating these patterns may assist not
only in enhancing our understanding of the dynamics of these behaviors, but also in developing
appropriate interventions.
Methods
Setting and participants
Participants were recruited into an ongoing network intervention study in St. Petersburg,
Russia. The study is a randomized controlled longitudinal trial involving IDUs and their
network members, and determines the efficacy of a network-orientated peer-educator
intervention to prevent HIV transmission among IDUs and members of their HIV risk network.
Participants were recruited using a combination of street outreach (convenience sampling) and
network referral (snowball sampling) methods. Those who were 18 years old or older and
injected drugs in the past 30 days were eligible to participate. Data on recruitment success were
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not collected or were not possible for those who were invited to participate by participants
already enrolled in the study, thus differences between participants and non-participants cannot
be assessed. Participants were provided food items (for the equivalent of about USD 10) as an
incentive to participate. After pre-test counseling, participants provided blood samples to test
for HIV and HCV. HIV antibodies were detected using two consecutive enzyme
immunological assays (EIA) (Vironostika HIV Uni-Form II plus O, Biomerieux, NL). Positive
HIV EIA tests were confirmed with Western Blot (New LAV Blot I, BioRad, France). HCV
antibodies were detected using Myrex anti-HCV (version 4.0) based on highly purified antigens
which contain sequences from the core, NS3, NS4 and NS5 regions of HCV. The study was
approved by the Institutional Review Boards of the Johns Hopkins Bloomberg School of Public
Health, Baltimore, MD, USA and the St. Petersburg University, St. Petersburg, Russia. This
report is based on data collected at baseline, between December 2004 and January 2007
(N=446), thus the analysis sample is part of the larger sample of the entire network study.
Measures and variables
After providing informed consent, participants were administered a structured, face-to-face
interview. Participants may have been intoxicated or undergoing withdrawal during the face-
to-face interviews, but all participants were capable of answering interview questions. No
information was collected on intoxication/withdrawal during the interview. The dependent
variables in this analysis were whether participants in the past 3 months engaged in receptive
syringe sharing after an HIV infected IDU (note: HIV infection of the sharing partner was
reported by the participant based on his/her knowledge); distributive syringe sharing; sharing
cookers (used to mix and heat the drugs) when not all syringes were new (i.e. sterile); sharing
filters (small pieces of material used to filter out large particles in the drug solution) when not
all syringes were new; and syringe mediated drug sharing (squirting drugs from one syringe
to another) when not all syringes were new. All dependent variables had response scales of
never, less often than once a week, 1–2 times a week, 3–4 times a week, 5–6 times a week,
every day, and were coded as yes (used at least once in the past 3 months) vs. no (did not use
in the past 3 months) to indicate any reported risk of disease transmission vs. no reported risk.
Independent variables included urban environment characteristics; social influence and social
norms; and individual variables. Urban environment characteristics were binary variables (yes
vs. no) unless specified otherwise, and included residential location (living in the Central,
Northern, Southern or another part of Saint Petersburg), homelessness, living with parents, and
obtaining syringes and drugs within the housing complex. Social influence and social norms
included descriptive social norms item (any of participant’s drug using peers talk about AIDS)
and prescriptive social norms item (any of participant’s drug using peers encouraged participant
to share injecting equipment) [11]. Individual variables were sociodemographic characteristics
(age; gender; being ever arrested), socioeconomic status (having a salary as the source of
income; having a total income of 8000 Rubles [about 300 USD] or less per month), drug use
variables in the past 3 month (injecting heroin daily; drinking alcohol daily; always cleaning
used syringes [with either bleach, alcohol, water only or water and soap]), primary involvement
in drug trade (combined variable: selling drugs or being middleman in drug sales), secondary
involvement in drug trade (being a “street doctor” [i.e., injecting others with drugs for a fee]);
knowledge of HIV status (participant reported not knowing their HIV status; reported being
HIV negative; and reported being HIV positive); and selling sex for money or drugs in the past
3 months.
Statistical analysis
Altogether five sets of analyses were performed (one for each of the dependent variables). For
each analysis, univariate analyses were conducted to select candidate variables for inclusion
in multivariate analyses. For the univariate analyses, chi-square p-values were used to assess
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association, and univariate logistic regression was used to calculate odds ratios and their 95%
confidence intervals. Statistically significant (p < 0.05) or marginally significant (0.05 < p <
0.20) variables were chosen for multivariate analyses. Multivariate logistic regression models
with backwards elimination were used to assess significant associations with the dependent
variables. Adjusted odds ratios (aOR) and 95% confidence intervals (95%CI) of the final
multivariate regression models are reported.
Results
Sample characteristics
The characteristics of the sample are described in Table 1. Altogether 44% tested positive for
HIV: among those who did not know their test results, 47% tested positive and among those
who self-reported being HIV negative, 14% tested positive (p<0.01; data not shown in table).
Almost all (96%) tested positive for HCV. The vast majority of participants (89%) reported at
least one sharing behavior. Pearson correlation coefficients (r) and corresponding p-values
(data not shown in table) show no correlation between receptive and distributive syringe
sharing (r=0.08, not significant); significant moderate correlation between syringe sharing
(receptive or distributive) and sharing other injecting equipment (sharing cookers or filters, or
backloading – r ranging between 0.16 and 0.22); and significant and strong correlation between
the different types of other injecting equipment sharing (sharing cookers or filters, or
backloading – r ranging between 0.46 and 0.72).
Correlates of injecting equipment sharing
Univariate significant correlates of injecting equipment sharing are shown in Table 2. In
multivariate analysis, urban environment variables that were significant correlates included
living with parents and buying drugs within the housing complex (sharing cookers); and
obtaining syringes within the housing complex (syringe mediated drug sharing) (Table 3). Of
the significant social influence and social norms variables, having drug using peers who
encouraged participants to share injecting equipment was associated with both receptive and
distributive syringe sharing and with sharing cookers. Significant correlates that measure
individual characteristics included younger age, which was correlated with both receptive and
distributive syringe sharing, injecting heroin daily was associated with distributive syringe
sharing; always cleaning used syringes was associated with all five dependent variables; and
secondary drug trade involvement (being a street doctor) was associated with sharing filters.
Having a salary income was negatively associated both with sharing cookers and with syringe
mediated drug sharing; and being employed full time was negatively associated with
distributive syringe sharing. Those who self-reported being HIV infected were significantly
more likely to report receptive syringe sharing and significantly less likely to report distributive
syringe sharing. (Self-report of being HIV negative was not significantly associated with either
receptive or distributive syringe sharing, but was kept in the models as a control variable.)
Discussion
In this analysis of IDUs in Saint Petersburg, Russia, we found that high-risk injection behaviors
were alarmingly common. We also found high levels of HIV infection in this population, and
that many of those who did not self-report being infected with HIV were actually infected. We
also discovered different patterns of association between the five injecting equipment sharing
behaviors and the levels of urban environmental characteristics, social influence and social
norms and individual attributes.
The association of urban environmental factors with equipment sharing may highlight issues
related to infection disclosure within social networks in small geographical units. For example,
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the association of sharing with obtaining drugs/syringes within the housing district implies
potential sharing with friends or acquaintances that live in the same neighborhood, and may
involve the issue of trust [19,20]. Disclosure of infection status may be important in such
relationships, and as such, it underlines the importance of voluntary counseling and testing
(VCT). In addition, it also highlights the importance of social networks not only in risk
behaviors, but potentially also in prevention interventions [21,22].
The importance of social influence and social norms in injecting equipment sharing has several
implications. Our finding that drug buddies’ encouraging to share was associated with both
receptive and distributive syringe sharing and with sharing cookers highlights the role of social
networks. Network interventions should aim at not only encouraging risk reduction
communication, but also discouraging communication among network members that would
promote risk behaviors [11].
Of the individual factors, self-reported HIV infection was a strong positive correlate of
receptive syringe sharing and a strong negative correlate of distributive syringe sharing. This
finding suggests that knowledge of seropositive status may not only lead to one’s own risk
reduction, but it may also lead to risk reduction towards others. A study among Hungarian
IDUs found that those who self-reported being HCV infected and not having an IDU sex partner
were more likely to practice receptive syringe sharing [23]. While such “informed
altruism” [14] may serve to protect those who do not self-report being HIV infected, it also
indicates that IDUs rely on a prevention method that is ineffective. Because of the high
incidence of HIV among IDUs in St. Petersburg, IDUs who have tested negative in the past
are not necessarily currently uninfected. In addition, our finding that those who self-reported
being uninfected with HIV were as likely as those who did not know their HIV status to use a
syringe after an HIV infected person, is also worrisome. Interventions among IDUs need to
include access to confidential testing services, rely on and emphasize existing norms of HIV
disclosure, and highlight the value of being uninfected with HIV [19]. Furthermore, VCT
programs should offer training in risk reduction as it relates to both self and others, as well as
information on serostatus and access to medical care. However, given the high level (over one
third) of distributive sharing among the positives who knew their status, it is likely that
expanded VCT will not be a sufficient mechanism to reduce syringe sharing.
Always cleaning used syringes was associated with all of the dependent variables in this
analysis, suggesting that prevention messages about injecting equipment cleaning may be
reaching their target. However, the question arises concerning the effectiveness of cleaning.
For example, Zule and colleagues suggest that the type of syringe used for injecting may
influence the efficacy of pathogen transmission: the detachable needle type (two-piece) syringe
retains more blood than the integral cannula type (one-piece) syringe, and is thus a more
effective vehicle of HIV transmission [24,25]. In addition, our unpublished ethnographic
findings in the region show that different types of syringes may be used for different types of
drugs: heroin is more often injected with one-piece syringes, while drugs purchased in liquid
form are almost always injected with two-piece syringes. Additional ethnographic studies are
needed to assess the injecting equipment cleaning process and its potential effectiveness in
preventing infection transmission [26,27], with a special emphasis on assessing the types of
syringes/needles used for the injecting process.
Of the other individual factors that were associated with injecting equipment sharing, being a
street doctor, being employed full time, and having a salary income are noteworthy. Sharing
filters may occur either during the injecting event while also using the same cooker, or after
the injecting event by retaining the filter and reusing it later [19]. Used filters, which contain
a small amount of drugs, are given to other drug users and may serve as a form of payment or
as trading favors [23]. As such, street doctors may be paid with used filters. Prevention
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programs need to address the potential of infection risk associated with non-sterile filters
[28]. In this study, the protective effect of being employed full time and having a salary income
suggests that higher socio-economic status IDUs may engage in lower-risk behaviors (and may
have lower odds of getting infected). They may have the resources to purchase drugs alone or
obtaining sterile equipment, or purchase more expensive, solid drugs instead of liquid drugs
in pre-loaded syringes that may require distributive syringe sharing or syringe mediated drug
sharing. Thus, focusing prevention programs on low socio-economic status IDUs and also
improving the socio-economic status of IDUs by promoting their social integration may lead
to risk reduction [29]. In addition, as Russia becomes a more prosperous country, higher
standards of living for most Russians may result in a general lowering of overall transmission
risk among IDUs.
The correlation patterns among five injecting equipment sharing variables and the different
patters of association between these behaviors suggest that different dynamics may be involved
in different types of injecting equipment sharing. The similarities suggest general approaches
for intervention, but the differences highlight that certain groups (e.g. daily heroin injectors
and IDUs who are not employed full time), may benefit from additional counseling related to
specific types of injecting equipment sharing (e.g. distributive syringe sharing).
One limitation of this analysis is the measurement error of all five dependent variables. Using
a syringe after an HIV infected IDU may be underreported since IDUs may not know that they
or their drug partners are infected. While self-reported HIV infection was the strongest correlate
of using a syringe after an HIV infected person, one might argue that this should be self-evident
since they were infected through sharing. However, syringe sharing in this study was reported
for the past 3 months, hence infected participants’ knowledge of their HIV infection most
probably preceded syringe sharing in this analysis. It is also possible, however, that individuals
who know that they are seropositive tend to report more receptive syringe sharing due to greater
recollection of sharing episodes and less distributive syringe sharing due to social desirability.
Another study limitation is that IDUs may not be aware that the syringes that are used to share
drugs are not new. Such measurement bias may result in obtaining lower levels of association
between the dependent and the independent variables, or finding no association when there is
one. Furthermore, for easier interpretation of our findings we recoded the original scales to
binary variables, and we did not assess associations related to frequency of sharing. In addition,
this sample was not a representative random sample of injecting drug users in St Petersburg,
Russia.
Based on the results of this analysis, we recommend that prevention interventions among IDUs
in St. Petersburg address urban environmental characteristics by means of structural
interventions, and also involve social network interventions and individual counseling [30].
Structural interventions may include preventing initiation of drug injecting by providing
meaningful activities for at-risk youth, and, for current IDUs, increasing the availability of
effective drug treatment programs, and working with the police and public health authorities
to enhance a public health oriented approach to drug use [6]. In addition, certain neighborhoods,
such as the South Side of St Petersburg, may be more characterized by risk environments than
other neighborhoods. Prevention work, such as greater access to syringe exchange and
pharmacies and access to one-piece syringes, need to be expanded in these neighborhoods. For
example, clean syringe distribution centers could be placed within housing complexes that
have a high prevalence of injection drug use, or injectors within these housing complexes could
be trained to serve as secondary syringe exchangers and to promote social norms that
discourage sharing of injection equipment. Lastly, disclosure of serostatus may play an
important role in this population. Thus, free and confidential HIV testing and counseling should
be more readily available for IDUs in St. Petersburg, including sending mobile testing units to
high-risk housing complexes and reducing stigma that may be associated with HIV infections.
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Table 1
Sample characteristics
Characteristic N (%)
Total 446 (100)
Age
 under 30 245 (54.9)
 30 or above 201 (45.1)
Gender
 male 298 (66.8)
 female 148 (33.2)
Education - high school or above 247 (55.4)
Neighborhood
 Center 116 (26.0)
 North 135 (30.3)
 South 176 (39.5)
 Other 19 (4.3)
Marital status
 single 207 (46.4)
 married 70 (15.7)
 living with a partner 120 (26.9)
 other 49 (11.0)
Has main partner 107 (24.0)
Has children 280 (62.8)
Homeless 1 (0.2)
Living with parents 236 (52.9)
Currently in school 11 (2.5)
Salary income 180 (40.4)
Employment status
 employed full time 63 (14.1)
 employed part time 112 (25.1)
 unemployed 271 (60.8)
Total income 8000 Rubles (USD 300) or less per month 198 (44.4)
Ever arrested 118 (26.5)
Self-reported HIV infection status
 don’t know 168 (37.7)
 self-reported HIV negative 187 (41.9)
 self-reported HIV positive 91 (20.4)
Laboratory confirmed HIV infection (n=404)* 177 (43.8)
Laboratory confirmed HCV infection (n=404)* 388 (96.0)
Daily heroin injector in past 3 months 243 (54.5)
Receptive syringe sharing after an HIV infected IDU 77 (17.3)
Distributive syringe sharing 217 (48.7)
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Characteristic N (%)
Shared cookers when not all syringes were new 339 (76.0)
Shared filters when not all syringes were new 327 (73.3)
Syringe mediated drug sharing (squirting drugs from one syringe to another) when not all syringes
were new
315 (70.6)
Reported any sharing (syringe, cookers, filters, backloading) 397 (89.0)
Note:
*
42 people did not have blood test results
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